date,title,source
Oct-30-18,Leading BioSciences Announces Appointments of James R. Neal and James Sapirstein to Board of Directors,GlobeNewswire
Oct-30-18,ContraVir Pharmaceuticals Completes Final Cohort Dosing in CRV431 Drug-Drug Interaction Study,GlobeNewswire
Nov-27-18,ContraVir Pharmaceuticals to Present CRV431 Preclinical Data at the Anti-Fibrotic Drug Development Summit,GlobeNewswire
Jan-15-19,ContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders,GlobeNewswire
Jan-16-19,"The Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen",Benzinga
Mar-04-19,ContraVir Pharmaceuticals Announces Panel Participation at 31st Annual ROTH Conference,GlobeNewswire
Apr-05-19,"Again, Durham pharma loses a drug development partner",American City Business Journals
Apr-11-19,ContraVir Pharmaceuticals to Present CRV431 Phase 1 Data at the International Liver Congress,GlobeNewswire
Apr-25-19,"ContraVir Pharmaceuticals, Inc. Announces Pricing of $2.14 Million Public Offering",GlobeNewswire
Apr-26-19,"The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug",Benzinga
